SentiAR

St. Louis, United States Founded: 2017 • Age: 9 yrs
A 3D visualization platform is offered for interventional cardiac procedures.

About SentiAR

SentiAR is a Healthcare company based in St. Louis (United States) founded in 2017 by Michael Southworth. A 3D visualization platform is offered for interventional cardiac procedures. It operates in the Healthcare and Technology sectors. SentiAR has raised $28.25 million across 11 funding rounds from investors including NIH, HHS and Arch Grants. The company has 8 employees. Its chief executive, as recorded, is Berk Tas. SentiAR offers products and services including CommandEP. Its focus areas include High Tech, Augmented Reality, Applications and Surgery Visualization. Its legal entity is SENTIAR, INC. Its competitors include Enhatch, Proximie and LensAR; 3 of its 3 listed competitors have raised funding.

Company details

Founded in 2017 and based in St. Louis, United States, SentiAR operates in the medical technology sector. A 3D visualization platform is developed for interventional cardiac procedures, utilizing a head-up display. Anatomic models are made visible to clinicians, supporting procedures that require precision. Leadership includes co-founder Michael Southworth and CEO Berk Tas. The platform is accessible via sentiar.com.

  • Headquarters St. Louis, United States
  • Employees 8
  • Founders Michael Southworth
  • Sectors
    Healthcare
    Technology
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Website sentiar.com
  • Social LinkedIn X
  • Legal Name Sentiar, Inc
Key Metrics
  • Total Equity Funding
    $28.25M (USD)

    in 11 rounds

  • Latest Funding Round
    $1.49M (USD), Series B

    Apr 2026

  • Investors
    NIH

    & 14 more

  • Employee Count
    8

Products & Services of SentiAR

SentiAR offers a comprehensive portfolio of products and services, including CommandEP.

CommandEP
AR Software

Creates interactive 3D visuals for heart procedures using real-time data.

Funding Insights of SentiAR

SentiAR has successfully raised a total of $28.25M across 11 strategic funding rounds. The most recent funding activity was a Series B round of $1.49 million completed in April 2026. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $28.25M
  • Total Rounds 11
  • Last Round Series B β€” $1.49M
  • First Round $1.1M

    (Aug 2017)

  • Investors Count 15

Latest 10 of 11 funding rounds of SentiAR with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Apr 2026$1.49MSeries B––
–
Apr 2025$2.47MSeries B––
–
Apr 2023$8.5MSeries B–cultivate(MD)
Apr 2021$5.1MSeries A––
Nov 2020$5.6MSeries A–TechWald Holding
Jan 2020$3MSeed––
–
Apr 2018$1MSeed––
–
Feb 2018$2.2MGrant––
Jan 2018$2.22MGrant––
Nov 2017$50,000Grant––
Valuation history

15 investors in total: 15 institutional.

Investors in SentiAR

SentiAR has secured backing from 15 investors, including venture fund and institutional investors. Prominent investors backing the company include NIH, HHS and Arch Grants.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
MedVenture Partners is focused on medical device venture investments.
2013medvp.co.jpTokyo, Japan
techwald.com
Venture capital investment opportunities are provided for accredited investors.
vcapital.com
Harmonix is focused on early-stage venture capital in health.
harmonixfund.comLa Quinta, United States
Venture capital funding for medical device companies is provided.
2017cultivate-md.comGrand Rapids, United States
Early-stage tech companies are funded by this venture capital firm.
cultivationcapital.comSt. Louis, United States
neuefund.com
Accredited investors are networked for private equity funding opportunities.
2000keiretsuforum.comSan Francisco, United States
Venture capital and acceleration are provided to life science startups.
biogeneratorventures.comSt. Louis, United States
Premium access

Investor details for SentiAR

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of SentiAR

6 people are tracked at SentiAR (3 in leadership, 3 in team); the tracked headcount is 8.

NameRoleGroup
Michael Southworth
Co-FounderLeadership
Berk Tas
CEOLeadership
Jennifer Avari Silva
Co-founder And CMOLeadership
Alexander Henry
Senior Software EngineerTeam
Chris Andrews
Principal Systems EngineerTeam
Ngan Le
Senior Software EngineerTeam
Premium access

Complete people profiles for SentiAR

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of SentiAR

3 dated milestones of SentiAR across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded SentiAR is founded.
  2. Funding First funding round of $1.1M.
  3. Funding Latest funding round, Series B, of $1.5M.

Competitors of SentiAR

SentiAR has 3 listed competitors in our database, 3 of them funded. They include Enhatch, Proximie and LensAR.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
enhatch.com2012Hoboken, United States$9.99M16
Provider of mobile enterprise apps for Salesforce
proximie.com2016Boston, United States$118.54M
Provider of a cloud-based VR platform for surgery guidance
lensar.com2004Orlando, United States$99.01M67
Laser and 3D imaging technology for cataract surgery is developed.
Premium access

Detailed competitors of SentiAR

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Clinical IT & Data Platforms

3 companies that operate in the same segment as SentiAR (Clinical IT & Data Platforms) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M1,365
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M1,746
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Sentiar

Premium access

Complete news archive for SentiAR

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about SentiAR

SentiAR was founded in 2017.

SentiAR is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.

Berk Tas is the CEO of SentiAR, as recorded in our data.

SentiAR is a funded company, having raised a total of $28.25M across 11 funding rounds to date. The company's 1st funding round was a Grant of $50K, raised on Aug 2017.

SentiAR has 8 employees.

Founded in 2017 and based in St. Louis, United States, SentiAR operates in the medical technology sector. A 3D visualization platform is developed for interventional cardiac procedures, utilizing a head-up display. Anatomic models are made visible to clinicians, supporting procedures that require precision. Leadership includes co-founder Michael Southworth and CEO Berk Tas. The platform is accessible via sentiar.com.

SentiAR's top competitors include LensAR, Proximie and Enhatch.

SentiAR offers CommandEP.

SentiAR has 15 investors. Key investors include NIH, HHS, Arch Grants, Keiretsu Forum, and MedVenture Partners.

SentiAR operates through Sentiar, Inc.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available